Weave Now Integrates with Neo
LEHI, Utah, July 21, 2025--(BUSINESS WIRE)--Weave (NYSE: WEAV), a leading all-in-one customer experience software platform for small and medium-sized healthcare businesses, today announced an integration with Neo, a leading cloud-based veterinary practice management software. This integration allows veterinarians to better manage their business through automation and optimization of tasks by unlocking the following Weave features:
Appointment Reminders and Confirmation Writebacks: Weave sends automated appointment reminders to clients to help keep schedules full and writes back their confirmation status in both systems.
Automated Data Sync: Keeps client contact and appointment information current in Weave with regular updates from the Neo database.
Phones and Call Pop: Displays the client's profile when they call into the practice, enabling staff to know more about clients when they call and deliver more personalized communications.
Vaccination Reminders: Automated text reminders help clients keep their pet's vaccinations up-to-date.
Reviews: Weave Reviews makes it easy for an office to collect and monitor reviews on Google and Facebook.
Missed-call Text: Never miss an opportunity with missed-call text messages whether you're away or busy with another client.
Text Writebacks: Vet Text Writebacks will enable office staff to easily transfer a text message to the PMS so that no important information in their care is lost and proper care is given with the doctors.
Weave empowers veterinary practices to attract, engage, and retain clients while streamlining operations and reducing administrative burdens. By providing intuitive tools that enhance communication and efficiency, Weave enables providers to focus on delivering exceptional care while building successful, patient-centered businesses. By streamlining payment processes with text-to-pay, online payments, and flexible options like payment plans, Weave accelerates collections, reduces write-offs, and improves practice profitability. To learn more about Weave's integration with IDEXX's Neo, visit getweave.com/integration/neo.
About Weave
Weave is the leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses. From the first phone call to the final invoice and every touchpoint in between, Weave connects the entire patient journey. Weave's software solutions transform how healthcare practices attract, communicate with, and engage patients and clients to grow their business. Weave seamlessly integrates billing and payment requests into communication workflows, streamlining payment timelines, reducing accounts receivable, and supporting practice profitability. In the past year, Weave has been named an Inc. Power Partner, a G2 leader in Patient Relationship Management software and a Top 50 Product for Small Business. To learn more, visit getweave.com/newsroom/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250721038008/en/
Contacts
Natalie HouseSenior Director of Content & Communicationspr@getweave.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Thermo Fisher beats quarterly estimates on resilient demand for its tools and services
(Reuters) -Thermo Fisher on Wednesday beat Wall Street estimates for second-quarter profit and revenue, helped by steady demand for its products and services used for developing therapies. Shares of the medical equipment maker were up 2.5% in premarket trading. The company joins peers such as Danaher in beating quarterly profit estimates, citing strong demand from the industry for tools and services used to make vaccines and therapies. Danaher said on Tuesday it is seeing a robust number of clinical trials and therapies under development, with steady demand from its pharmaceutical clients. On an adjusted basis, Thermo Fisher reported a profit of $5.36 per share for the quarter ended June 28, beating analysts' estimate of $5.22 per share, as per data compiled by LSEG. The company said its business strategy called "practical process improvement" is helping adjust its supply chains in the tariff environment and to actively manage its cost base. Last week, the company said it will buy French drugmaker Sanofi's New Jersey manufacturing site, "to meet growing demand from pharma and biotech customers." The Waltham Massachusetts-based company's quarterly revenue rose 3% to $10.85 billion, compared to analyst estimates of $10.68 billion. Sales at its laboratory products segment, which makes up more than half of Thermo Fisher's total sales came in at $6 billion, above estimates of $5.79 billion. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 minutes ago
- Yahoo
Highly shorted Krispy Kreme, GoPro jump as meme stock rally continues
(Reuters) -Shares of some highly-shorted companies, including Krispy Kreme and GoPro, jumped in premarket trading on Wednesday, aided by their names trending on social media forums a day after retail traders piled into department store company Kohl's. Doughnut chain Krispy Kreme jumped 16.1%, building on a near 27% surge on Tuesday. About 14% of Krispy Kreme's outstanding shares available for trading are shorted, according to data compiled by LSEG. Camera maker GoPro also surged about 47% to $2.01. Short interest on the stock was last at 7.7%. Another highly shorted stock - with short interest at 36.7% - was plant-based meat company Beyond Meat, whose shares jumped 10.4% on Wednesday. The growing interest in heavily shorted stocks comes after Kohl's surged 37.6% higher in volatile trading on Tuesday on the back of high retail interest. Mom-and-pop traders bought $9.64 million of its shares that day, the most by this category of investors in about three years, according to data from Vanda Research. Kohl's was flat in premarket trading on Wednesday but is the third most trending ticker on Stocktwits, a retail investor-focused social media platform. Among other highly shorted names, online gifts retailer rose 8.1%. Opendoor Technologies, which has rocketed 440% so far this month, was down 2.6% on Wednesday.
Yahoo
17 minutes ago
- Yahoo
Thermo Fisher shares climb as Q2 top and bottom line exceed estimates
-- Thermo Fisher Scientific Inc (NYSE:TMO) reported second-quarter earnings that topped expectations, with revenue also coming in ahead of forecasts. The company reported adjusted EPS of $5.36, beating the analyst estimate of $5.23. Revenue rose 3% from a year earlier to $10.85 billion, above the $10.68 billion consensus. Shares in the medical equipment maker were up 2.3% in premarket trading Wednesday as of 06:06 ET. 'Our exceptional team continues to execute at a high level, enabling customer success while navigating the macroenvironment," said Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific. Adjusted operating income reached $2.38 billion, slightly up from $2.35 billion in the same period last year. Adjusted operating margin slipped to 21.9% from 22.3% a year ago. Related articles Thermo Fisher shares climb as Q2 top and bottom line exceed estimates These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia If Powell goes, does Fed trust go with him?
